Happy Fourth of July from all of us at Eurofins Diatherix! In Observance of Independence Day, Eurofins Diatherix will be CLOSED on Thursday 7/4/2024 and REOPEN Friday, 7/5/2024 at 8am for regular hours of operation. REGULAR HOURS OF OPERATION All Hours in Central Time (CT) MONDAY – FRIDAY: 8am – 7pm Laboratory and Client Services SATURDAY: 8am – 4:30pm Laboratory and Client Services
Diatherix’s Post
More Relevant Posts
-
The best in the #Haemostasis #Coagulation spectrum. BIOCOM Africa Technoclone #WEareBIOCOM #technoclone #Coagulation #ADAMTS13 #VWF #CEVERONS100 #TGA #PT #PTT #DDIMER #THROMBINGENERATION #CAPTEINCEVERON #Bleedingdisorders #Clotting #Clottingcascade #cascade #TTP
Don’t miss to visit #CaptainCeveron 🤖, Alex Santos & Marco Wolf at the UK NEQAS meeting on Clinical and Laboratory #Hemostasis at the Eurobio Scientific UK booth and to learn more about the great portfolio of speciality test of #Technoclone 🤩! . For further information on TECHNOCLONE products in the UK please contact Mr Alex Santos from Eurobio Scientific UK 🇬🇧 !
To view or add a comment, sign in
-
-
Have you joined yet ? why not join this free webinar to learn more about the #synbiotic concepts that we have developed in collaboration with Probi AB it might just give you an opportunity to learn more about our Bimuno #prebiotic and #probiotic combination that are synergistically suitable for your #supplements. #microbiome #guthealth #immunehealth #synbiotics
We're excited to announce that we're co-hosting a webinar alongside Probi AB on June 4th at 15:00 CET - "Exploring synbiotics: when cutting edge science meets market potential" Join us as our panel of experts, including our very own Dr Lucien Harthoorn, Dr. Frederic Narbel, DBA in addition to Dr Caroline Montelius, and Dr Christina Skovgaard Vegge from Probi, discuss the latest synbiotic trends, insights from recent synbiotic research demonstrating a synergistic relationship, and how synbiotics can add scientific value to meet not just today's but tomorrow’s consumer needs. Click the link in the comments below to sign up now and secure your spot! 👇 #Synbiotics #Webinar #Prebiotics
To view or add a comment, sign in
-
-
Are you working in the DILI field and interested to learn how #organonchip can improve assay sensitivity vs traditional in vitro technologies and refine in vivo study design by bridging the gap? Lead Scientist Dr Emily Richardson is re-running her presentation of our latest/new data as presented at SOT....register to listen in using the link below!
Couldn't make it to CN Bio 's lunchtime seminar on Early Identification of DILI with in vitro human and animal MPS at SOT and ToxExpo this year? We had a packed house and tons of interest after the presentation! Don't worry, we've got you covered! Join us for a virtual follow-up seminar featuring Dr. Emily Richardson, who will present the same valuable material. Reserve your spot now! 👉 https://lnkd.in/e_X_Q9Ms #CNBioAt #VirtualSeminar #DILI #NAM
To view or add a comment, sign in
-
We're excited to announce that we're co-hosting a webinar alongside Probi AB on June 4th at 15:00 CET - "Exploring synbiotics: when cutting edge science meets market potential" Join us as our panel of experts, including our very own Dr Lucien Harthoorn, Dr. Frederic Narbel, DBA in addition to Dr Caroline Montelius, and Dr Christina Skovgaard Vegge from Probi, discuss the latest synbiotic trends, insights from recent synbiotic research demonstrating a synergistic relationship, and how synbiotics can add scientific value to meet not just today's but tomorrow’s consumer needs. Click the link in the comments below to sign up now and secure your spot! 👇 #Synbiotics #Webinar #Prebiotics
To view or add a comment, sign in
-
-
Interesting webinar on human cell culture technology including good cell culture practice (#GCCP, #3R, #invitrotoxicology) held by Regina Grillari #Evercyte!
LifeSaver Project invites you to our upcoming training event on Tissue dissociation and establishment of primary human cell cultures, hosted by Evercyte GmbH The event is scheduled for Wednesday, 20th September from 10:00 - 12:00 GMT+2. To register click on this link. https://lnkd.in/evrKxUda #LifeSaverH2020 #H2020 #EUFunded #EUHealthResearch #LifeSaverProject #LIFESAVER #events #cellculture
To view or add a comment, sign in
-
What are the practical considerations for developing and validating an NGS-based assay? Learn from #molpath experts at 2023 Get AMPed! in Salt Lake City this November. Advanced registration rates end October 20: https://ow.ly/y54350PCFjX #AMPath23
To view or add a comment, sign in
-
-
🎙️Check out our discussion with Mayukh Sukhatme, MD, President and CIO of Roivant Sciences, about their recent dealmaking and their drug discovery and development philosophy! https://ow.ly/55zJ50PykeY
To view or add a comment, sign in
-
-
For Novartis CEO Vas Narasimhan, arguably the most important part of the company makeover is in R&D. Simone Fishburn talked to him about how he's reshaping R&D and what areas he wants the company to dominate. Plus, what his China strategy is for research. Part 2 of the interview, via BioCentury Inc.
To view or add a comment, sign in
-
🔍 𝗧𝗵𝗲 𝟯 𝗺𝗮𝗶𝗻 𝗿𝗲𝗮𝘀𝗼𝗻𝘀 𝘁𝗼 𝘂𝘀𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵-𝗴𝗿𝗮𝗱𝗲 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀 👨⚕️ There are reasons for preferring not licensed molecules for research over clinical-grade ones. Dr. Benjamin Müller, CEO and co-founder of the (bio)analytical company Biofidus AG, shares the top three reasons in an insightful interview. 🔗 For more information, check our website (link in the comments)! #Biosimilars #AntibodyResearch #RnD #DrugDevelopment #ClinicalGrade 🧪✨ Dr. Peter Spieth | Dr. Christian Schmitz
The 3 main reasons to use research-grade molecules
To view or add a comment, sign in
-
I had an opportunity to host our FAS Kyle Nilson to talk about using knowledge bases and omics data sources in target identification and then further insilico validation. It ended up being a fascinating chat with a few attendees chiming in with questions. Check out this great new webinar: https://lnkd.in/dZGM8vRx #drugdiscovery #drugdevelopment #bioinformatics #datascience
To view or add a comment, sign in
-